Peter Suma

Peter is a co-CEO of Applied Brain Research Inc. Prior to ABR, Peter led start-ups in robotics and financial services as well as managed two seed venture capital funds. Peter holds degrees in systems engineering, science, law and business.

Jason Nurse

Dr Jason R.C. Nurse is an Associate Professor in Cyber Security at the Institute of Cyber Security for Society (iCSS) at the University of Kent, UK. He is also a Visiting Academic at the University of Oxford, and Associate Fellow at the Royal United Services Institute for Defence and Security Studies (RUSI). Dr Nurse specialises in a diverse set of topics including security culture and awareness in business, corporate communications after cyber incidents, cyber insurance and issues of ransomware. He has published over 100 peer-reviewed research articles and he has had his research featured in national and international media including Newsweek, BBC, Associated Press, Wall Street Journal, ComputerWeekly and The Conversation. Dr Nurse was selected as a Rising Star for his research into cybersecurity, as a part of the UK’s Engineering and Physical Sciences Research Council’s Recognising Inspirational Scientists and Engineers (RISE) awards campaign.

David Caballero-Lima

David received his undergraduate degree in Biology and his PhD in Biomedical Sciences from the Universidad de Extremadura in Spain. David took postdoctoral research positions at the University of Sheffield and the University of Manchester, with both roles focusing on studying human/pathogen interaction  via tissue models and obtaining a greater understanding in the regulation of the  cell cycle and  vesicle transportation during morphological changes.  In addition he was involved in the development of point-of-care diagnostic devices for diseases such as fungal and bacterial keratitis and novel antifungal discovery.  

David was initially Services Manager at Labskin, responsible for all microbiology work and service projects, bringing his 18 years’ experience working with microbiology and host-pathogen interactions. 

As Head of R&D, David now leads the research department, focusing on the development of new methods for studying the native skin microflora, prebiotic, probiotics and antimicrobial effects of ingredients and formulation for pharmaceutical and cosmeceutical studies. He is also the scientific lead for the development of Labskin new consumers service; Skin Trust Club, a new concept of personalised skin care based on the analysis of the skin microbiome.  David is a key collaborator on international research bids, as a peer with leading international experts from academia and industry.

Kimberly Shenk

Dianna Rith

Richard Clode

Richard Clode is a Portfolio Manager at Janus Henderson Investors, a position he has held since joining Henderson in 2014. He is co-lead manager of the Global Technology Leaders and Sustainable Future Technologies strategies. Prior to Henderson, Richard held positions with Gartmore, Moore Capital, Pioneer Investments and Herald Investment Management. Richard received a first class honours degree in modern history from the University of Oxford. He holds the Chartered Financial Analyst designation and has 18 years of financial industry experience.

Anthony TA

Anthony is leading the Blockchain, DLT and Privacy Enhancing Technologies innovation at SG.

He started as Pan European Equity Sales Trader in 2001 at SG Singapore and pursued his career with SG in the UK, Hong Kong, and France.

Since 2018, he joined the innovation department of SGCIB as a Project Director/Innovation & Watch Leader and is focusing on all technologies that enable, enhance and preserve data privacy throughout its lifecycle.

Niels Verhulst

Niels acquired his PhD at Wageningen University, The Netherlands and is now a senior researcher at the University of Zürich leading a group of scientists working on the behavioural ecology of mosquitoes.  

He studies how skin microbial volatiles influence the attractiveness of humans and animals to mosquitoes. His goal is to develop novel skin bacterial based products that can reduce mosquito bites and thereby pathogen transmission.